Polymerase compositions and methods
Disclosed herein are modified polymerase compositions exhibiting altered polymerase activity, which can be useful in a variety of biological applications. Also disclosed herein are methods of making and using such compositions. In some embodiments, the compositions exhibit altered properties that can enhance their utility in a variety of biological applications. Such altered properties, can include, for example, altered nucleotide binding affinities, altered nucleotide incorporation kinetics, altered photostability and/or altered nanoparticle tolerance, as well as a range of other properties as disclosed herein.
1. A method for performing a primer extension reaction, comprising:
contacting a modified polymerase comprising an amino acid sequence that is at least 98% identical to the amino acid sequence of SEQ ID NO: 7 with a nucleic acid molecule and at least one nucleotide under conditions where the at least one nucleotide is incorporated into the nucleic acid molecule by the polymerase;
wherein the modified polymerase has amino acid leucine at position 383 and amino acid asparagine at position 384 and one or more additional amino acid modifications, and the modified polymerase exhibits increased polymerase activity relative to the unmodified reference B103 polymerase, SEQ ID NO: 6, and wherein the one or more additional amino acid modifications of the modified polymerase consist of:
i) one or more amino acid substitutions, additions or deletions at one or more positions selected from the group consisting of: 9, 11, 12, 58, 59, 63, 162, 166, 377 and 385, and the modified polymerase exhibits reduced exonuclease activity relative to an unmodified B103 polymerase, SEQ ID NO: 6;
ii) one or more amino acid substitutions at one or more positions selected from the group consisting of: 365, 370, 371, 372, 481, 507, and 509, wherein the one or more amino acid substitutions at position 372 is selected from the group consisting of K372G, K372T, K372S, K372R, K372A, K372Q, K372W, K372Y, and K372F, and the modified polymerase exhibits an increased branching ratio and/or increased nucleotide binding affinity relative to a reference modified polymerase of SEQ ID NO: 7; and/or
iii) an amino acid substitution at position 380, and the modified polymerase exhibits increased t po1 value (or decreased k po1 value) relative to the unmodified B103 polymerase, SEQ ID NO: 6.
2. The method of claim 1 , wherein the at least one nucleotide is a labeled nucleotide, and the label of the nucleotide emits a signal during incorporation of the nucleotide.
3. The method of claim 2 , further comprising detecting the signal emitted by the nucleotide label.
4. The method of claim 2 , wherein the labeled nucleotide is a reversible terminator.
5. The method of claim 2 , wherein the modified polymerase is linked to a label.
6. A method for detecting one or more nucleotide incorporations onto the end of a single nucleic acid molecule, comprising:
contacting a target nucleic acid molecule with a modified polymerase comprising an amino acid sequence that is at least 98% identical to the amino acid sequence of SEQ ID NO: 7 with one or more labeled nucleotides under conditions where at least one labeled nucleotide is incorporated by the polymerase onto the end of an extending nucleic acid molecule, wherein the label of at least one labeled nucleotide emits a signal indicative of nucleotide incorporation; and
detecting the one or more signals indicative of nucleotide incorporation,
wherein the modified polymerase has amino acid leucine at position 383 and amino acid asparagine at position 384 and one or more additional amino acid modifications, and the modified polymerase exhibits increased polymerase activity relative to the unmodified reference B103 polymerase, SEQ ID NO: 6, and wherein the one or more additional amino acid modifications of the modified polymerase consist of:
i) one or more amino acid substitutions, additions or deletions at one or more positions selected from the group consisting of: 9, 11, 12, 58, 59, 63, 162, 166, 377 and 385 and the modified polymerase exhibits reduced exonuclease activity relative to an unmodified B103 polymerase, SEQ ID NO: 6;
ii) one or more amino acid substitutions at one or more positions selected from the group consisting of: 365, 370, 371, 372, 481, 507, and 509, wherein the one or more amino acid substitutions at position 372 is selected from the group consisting of K372G, K372T, K372S, K372R, K372A, K372Q, K372W, K372Y, and K372F, and the modified polymerase exhibits an increased branching ratio and/or increased nucleotide binding affinity relative to a reference modified polymerase of SEQ ID NO: 7; and/or
iii) an amino acid substitution at position 380 and the modified polymerase exhibits increased t po1 value (or decreased k po1 value) relative to the unmodified B103 polymerase, SEQ ID NO: 6.
7. The method of claim 6 , further comprising analyzing the one or more detected signals emitted by the nucleotide label to determine the presence of a target nucleic acid molecule.
8. The method of claim 6 wherein the detecting is performed in real time or near real time of the incorporation.
9. The method of claim 6 , wherein the labeled nucleotide is a reversible terminator.
10. The method of claim 6 , wherein the modified polymerase is linked to a label.
11. The method of claim 7 comprising identifying the target nucleic acid molecule.
12. The method of claim 7 comprising determining the sequence of some or all of the sequence of the target nucleic acid molecule.
13. A method for sequencing a nucleic acid molecule, comprising:
(a) conducting a polymerase reaction comprising contacting a target nucleic acid molecule with a modified polymerase comprising an amino acid sequence that is at least 98% identical to the amino acid sequence of SEQ ID NO: 7 with one or more labeled nucleotides under conditions where at least one labeled nucleotide is incorporated by the polymerase onto the end of an extending nucleic acid molecule, wherein the target nucleic acid molecule is paired with a polymerization initiation site and wherein the label of at least one labeled nucleotide emits a signal indicative of nucleotide incorporation; and
(b) detecting a time sequence of nucleotide incorporations from the one or more signals indicative of nucleotide incorporation; and
(c) determining the identity of one or more incorporated nucleotides, thereby determining some or all of the nucleotide sequence of a single nucleic acid molecule,
wherein the modified polymerase has amino acid leucine at position 383 and amino acid asparagine at position 384 and one or more additional amino acid modifications, and the modified polymerase exhibits increased polymerase activity relative to the unmodified reference B103 polymerase, SEQ ID NO: 6, and wherein the one or more additional amino acid modifications of the modified polymerase consist of:
i) one or more amino acid substitutions, additions or deletions at one or more positions selected from the group consisting of: 2-9, 11, 12, 58, 59, 63, 162, 166, 377 and 385 and the modified polymerase exhibits reduced exonuclease activity relative to an unmodified B103 polymerase, SEQ ID NO: 6;
ii) one or more amino acid substitutions at one or more positions selected from the group consisting of: 365, 370, 371, 372, 481, 507, and 509, wherein the one or more amino acid substitutions at position 372 is selected from the group consisting of K372G, K372T, K372S, K372R, K372A, K372Q, K372W, K372Y, and K372F, and the modified polymerase exhibits an increased branching ratio and/or increased nucleotide binding affinity relative to a reference modified polymerase of SEQ ID NO: 7; and/or
iii) an amino acid substitution at position 380 and the modified polymerase exhibits increased t po1 value (or decreased k po1 value) relative to the unmodified B103 polymerase, SEQ ID NO: 6.
14. The method of claim 13 , further comprising analyzing each of the one or more detected signals emitted by the nucleotide label to determine the sequence of a target nucleic acid molecule.
15. The method of claim 13 wherein the detecting is performed in real time or near real time of the incorporation.
16. The method of claim 13 , wherein, the labeled nucleotide comprises a nucleotide label linked to the base, sugar, or phosphate group of the nucleotide.
17. The method of claim 13 , wherein the labeled nucleotide is a reversible terminator.
18. The method of claim 13 , wherein the modified polymerase is linked to a label.
19. The method of claim 17 wherein the reaction is detected and monitored in real time based on detection of FRET signals.
20. The method of claim 14 comprising determining the sequence of some or all of the sequence of the target nucleic acid molecule.